Health

Health
HeathCare
TradersPro Alerts

Mirati Therapeutics, Inc. (MRTX) Buy Target $102.10 Sell Target $113.75

Trade Setup Buy Target $102.10 Sell Target $113.75 Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company is involved in developing sitravatinib, a spectrum-selective kinase inhibitor, which is in Phase II clinical for the treatment of non-small cell lung […]

Read More
Biomedical
Health
HeathCare
TradersPro Alerts

DURECT Corporation (DRRX) Buy Target $2.48 Sell Target $3.04

Trade Setup Buy Target $2.48 Sell Target $3.04 DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers […]

Read More
Health
HeathCare
TradersPro Alerts

Akari Therapeutics, Plc (AKTX) Buy Target $2.05 Sell Target $2.28

Trade Setup Buy Target $2.05 Sell Target $2.28 Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases. 

Read More
Donald Trump
Health
Health Insurance
HeathCare
Stock Picks

Why One Analyst Says To Buy The Dip In These 3 Managed Care Stocks

Any pressure on these 3 managed care stocks is a buying opportunity according to one Cantor Fitzgerald analyst.

Read More
Health
HeathCare
TradersPro Alerts

Spero Therapeutics, Inc. (SPRO) Buy Target $10.16 Sell Target $11.04

Trade Setup Buy Target $10.16 Sell Target $11.04 Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections in the United States. Its product candidate includes SPR994, an oral carbapenem-class antibiotic to treat MDR gram-negative infections for adults; SPR741, which is in Phase Ib […]

Read More
Amazon
China
Daily Rundown
Electric Vehicles
Health
Industrial Sector
Industrials
Pet Therapeutics
Retailers
Specialty Retailers
Stock Picks

Express Shares Are Skyrocketing On News Of Store Closures & New Business Strategy

Plus, the UN has called for an investigation into whether the Saudi Crown Prince was involved in hacking Amazon’s Bezos’ iPhone, Tesla got another upgrade, and Boeing said it doesn’t expect regulatory approval for its 737 Max until mid-year.

Read More
Health
HeathCare
TradersPro Alerts

Pieris Pharmaceuticals, Inc. (PIRS) Buy Target $3.52 Sell Target $3.80

Trade Setup Buy Target $3.52 Sell Target $3.80 Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs in the United States. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids. Its […]

Read More
Health
TradersPro Alerts

Curis, Inc. (CRIS) Buy Target $1.79 Sell Target $2.10

Trade Setup Buy Target $1.79 Sell Target $2.10 Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CUDC-907, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered […]

Read More

FREE TRAINING - TRADERSPRO PRESENTS: Retire In 18 Months With $2.4 Million?

Join Us Now
X